Guidance

The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Deep dermal injection of non absorbable gel polymer for HIV-related facial lipoatrophy.

This document replaces previous guidance on deep dermal injection of non absorbable gel polymer for HIV-related facial lipoatrophy (NICE interventional procedure guidance 291, March 2009).

Description

HIV-related lipoatrophy is a loss of fat from the skin, often the face, which can occur as a side effect of antiretroviral drug treatment for HIV. Non-absorbable gel polymers are water-based synthetic substances that are not broken down by the body. The gel polymer is injected under the skin to restore the shape and volume of the areas where fat has been lost.

Coding recommendations

S50.4 Injection of inert substance into subcutaneous tissue NEC

Z47.- Skin of face

Includes: Subcutaneous tissue of face

Endorsing bodies

This interventional procedures guidance is endorsed by Healthcare Improvement Scotland as required by the Health and Social Care Act (2012).

  • National Institute for Health and Care Excellence (NICE)